Avita Medical (ASX:AVH) has appointed interim replacements for its CEO and chairman and has started reviewing its remuneration policy following last month's 'first strike' vote. [ + ]

The Scottish Medicines Consortium (SMC) has accepted Bronchitol for use by the nation's National Health Service as an adjunct therapy in adult cystic fibrosis patients. [ + ]

Bowel cancer research has received a $15 million gift. [ + ]

European researchers have found that, by modifying simple imaging devices into mini microscopes, they can prevent the misdiagnosis of parasitic infections - particularly in resource-deficient areas where such infections are common. [ + ]

An international research team has discovered more than 30 new - and so far unclassified - species of Antarctic marine life. After a lengthy categorisation period, their findings have been published in the journal Continental Shelf Research. [ + ]

Mexican entrepreneurs have developed a system capable of using vehicular flow to generate electric energy. This development has the potentiality to produce sufficient electricity to power up a household through a device that 'catches' the force of the moving cars. [ + ]

Starpharma (ASX:SPL) CFO Nigel Baade will take on the responsibilities of company secretary Ben Rogers who is retiring, effective from Friday. [ + ]

Wyatt Technology has published an application note highlighting a study on the complex interactions between proteins and how they modulate the rotational direction of bacteria flagella. The application note highlights the benefit of using composition-gradient multi-angle static light scattering (CG-MALS) to confirm the specific binding sites of the protein. [ + ]

The Tax Laws Amendment (Research and Development) Bill 2013 will proceed to the Senate after being debated and passed in the House of Representatives without amendment this week. [ + ]

With the initial public offering (IPO) of medical device distributor LifeHealthcare Group last week and the IPO launch of New Zealand-based Innate Immunotherapeutics the week prior, expectations are growing that we will see a reawakening of the biotechnology IPO market the coming year. [ + ]

Increasing levels of carbon dioxide are having an adverse effect on the diversity of invertebrates that live on coral reefs. [ + ]

Ascend Biopharmaceuticals has entered an agreement with 3M Drug Delivery Systems to evaluate conjugating a 3M agonist with Ascend's ASN cancer vaccine platform. [ + ]

New data from a Biotron (ASX:BIT) study of its BIT225 drug candidate suggest it can reduce the quantity of virus in HIV reservoir cells as well as stopping HIV replication. [ + ]

A virtual trial of Genetic Technologies' (ASX:GTG) BREVAGen genetic test for breast cancer risk shows it is most cost-effective in women with an intermediate risk. [ + ]

Massey University researcher Dr Esther Swee Lan Chong has found that potatoes may have cancer-fighting properties. [ + ]